Production (Stage)
Lotus Pharmaceuticals, Inc.
LTUS
$0.005
-$0.0009-15.25%
OTC PK
| 09/30/2011 | 06/30/2011 | 03/31/2011 | 12/31/2010 | 09/30/2010 | |
|---|---|---|---|---|---|
| Net Income | -29.34% | -20.64% | 163.39% | -152.63% | 5.97% |
| Total Depreciation and Amortization | -0.15% | 0.76% | -55.21% | 103.31% | 0.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -100.00% | -72.38% | 6,031.42% | -40.19% |
| Change in Net Operating Assets | 158.65% | 177.07% | -141.71% | 0.84% | 936.93% |
| Cash from Operations | 26.72% | -13.20% | -54.31% | -22.57% | 51.67% |
| Capital Expenditure | -31.52% | 1.86% | 51.32% | 28.03% | -53.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -31.52% | 1.86% | 51.32% | 28.03% | -53.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -98.14% | 91.67% | -78.68% | 78.28% | 351.02% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -71.38% | -1,363.79% | -106.56% | 344.23% | -289.46% |